|
|
||||||||
lhami Uslu
ükrü Bozluolçay
lu
rfan Urgancio
lu
Department of Nuclear Medicine, Cerrahpa
a Medical Faculty, Istanbul, Turkey
Correspondence: For correspondence or reprints contact: Levent Kabasakal, MD, Nükleer Tip Anabilim Dal
Cerrahpa
a Tip Fakültesi, Aksaray, Istanbul, Turkey.
ABSTRACT
Technetium-99m-labeled N,N-ethylenedicysteine (99mTc-EC) is a new renal imaging agent introduced as an alternative for 99mTc-labeled mercaptoacetyltriglycine (99mTc-MAG3), with similar renal excretion characteristics. To evaluate the diagnostic characteristics of this agent, a gamma camera study was performed. Methods: Sixteen patients with obstructive renal disease and six normal controls were injected with 90 to 110 MBq of 99mTc-EC and 7.4 MBq 131I-labeled orthoiodohippurate (OIH). Serial images were obtained during 20 min for 99mTc-EC and 30 min for OIH. The study was repeated using 90 to 110 MBq 99mTc-MAG3 during the same week. Results: Renograms, functional ratios and urinary excretion patterns of all three agents were similar. The mean time to peak activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 4.25 ± 0.37 min, 4.39 ± 0.32 min and 4.00 ± 0.24 min, respectively. The time from peak to 50% activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 5.48 ± 0.80 min, 6.93 ± 0.69 min and 7.33 ± 0.85 min, respectively. Conclusion: It is concluded that 99mTc-EC has excellent imaging characteristics and similar excretion properties to OIH. The advantages of 99mTc-EC over 99mTc-MAG3 are lower hepatobiliary uptake and simplicity of preparation.
Key Words: ethylenedicysteine MAG3 OIH renogram
This article has been cited by other articles:
![]() |
D. Eshima, L. Eshima, L. Hansen, M. Lipowska, L. G. Marzilli, and A. Taylor Jr Effect of Protein Binding on Renal Extraction of 131I-OIH and 99mTc-Labeled Tubular Agents J. Nucl. Med., December 1, 2000; 41(12): 2077 - 2082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |